EPC vs PG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
EPC presents a stark contradiction between operational health and valuation. While the Piotroski F-Score of 7/9 indicates strong short-term financial health and operational stability, the company is fundamentally overvalued relative to its Graham Number ($8.87) and Intrinsic Value ($0.77). A catastrophic YoY EPS decline of -328.6% and an unsustainable dividend payout ratio of 545.45% signal severe earnings distress, despite a bullish analyst consensus based on a low Forward P/E.
PG exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is severely overvalued relative to its deterministic baselines. The current price of $145.71 represents a massive premium over the Graham Number ($58.45) and Intrinsic Value ($47.25), while a PEG ratio of 3.92 indicates the valuation is disconnected from its stagnant growth. Negative earnings growth (-5.40% YoY) combined with bearish insider activity and a 0/100 technical trend suggests significant downside risk despite the company's operational efficiency.
Compare Another Pair
Related Comparisons
EPC vs PG: Head-to-Head Comparison
This page compares Edgewell Personal Care Company (EPC) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.